I'm going to start by being clear - I'm no legal expert - so I'm not going to dissect in details the legal case. But what I am going to do is bring together several pieces from the two court dockets that give some indications about the program, give insights from the discovery about the iPlatform, Verb and Ottava programs.
What I really want to dive into is the management - or mismanagement of a surgical robotic program - and give my thoughts on what are the classic errors in developing complex programs - especially if teams have little to no understanding of the complexities around Robotic Assisted Surgical Devices (RASD).
I'm going to pull out some incredible numbers that are in these dockets - that will almost spell the word - "Delusion" and explain why those bullish numbers and timelines were not achievable and are most likely now even further out of reach.
I'll cover the bizzarity of surgical procedure selection - that as I'd long suspected, was driven not by the robotic platform - but by the need to get to highly lucrative staplers and energy devices.
And what that could imply for the pending Ottava launch - which according to these documents is the merged offspring of “the best of iPlatform and the best of Verb”
Which is never good to create chimeras of surgical robots.
So read on…
Comments